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Introduction
The high recurrence rate (30%) after surgery for 
pelvic organ prolapse (POP) makes a more refined
reconstructive surgery imperative [1]. There are some
risk factors for POP recurrence, e.g. poor tissue quality
before and during surgery, impaired healing, chronic
diseases causing increased intra-abdominal pressure
(due to obstructive pulmonary disease, asthma or con-
stipation), high-grade cystocele, and age 60 years or
older [2,3]. Patients with risk factors may benefit from
adjuvant prosthetic materials during pelvic reconstruc-
tive surgery. Therefore, biological and synthetic prosthe-
ses have emerged as adjuvant prosthetic materials [4].
Through the evolution of pelvic reconstructive surgery,
prostheses have played important roles as reinforcement
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The high recurrence rate of pelvic organ prolapse (POP) of up to 30% after pelvic reconstructive surgery makes 
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supportive tissue; (2) to reinforce inadequate tissue; (3) to induce new supportive tissue; and (4) to consolidate
and complement the insufficient surgical techniques. However, some debatable issues in use of the prosthetics
remain. The use of prosthetics enables the simultaneous repair of all vaginal defects of POP and concomitant
anti-incontinence surgery to be faster, easier and more precise. Nevertheless, great care should be devoted to
the actual and theoretical short- and long-term risks, many of which have not been fully elucidated. Despite the
lack of various ideal characteristics, the type I monofilament, macroporous polypropylene, has been suggested
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to support the use of nonabsorbable synthetic mesh for abdominal sacrocolpopexy, while the use of prostheses
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long-term studies with sufficient patient numbers to prove whether synthetic or biological prostheses are superior
during vaginal surgery. Tension-free vaginal mesh techniques with procedural kits are being adopted increas-
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adjuvant (Figure). Once a successful material is identi-
fied or developed, it may decrease operating time and
morbidity during vaginal surgeries. However, some de-
batable issues in the use of prostheses for pelvic floor
reconstructive surgery remain.
Prostheses can serve as a scaffold for tissue in growth
after pelvic reconstructive surgery with the purpose to:
(1) substitute for the lack of supportive tissue; (2) rein-
force inadequate tissue; (3) induce new supportive tissue
growth; and (4) consolidate and complement insuffi-
cient surgical techniques [5]. With the use of prosthe-
ses, the surgeon can repair all vaginal defects faster,
easier and more accurately. In the anterior compart-
ment, a graft can be anchored bilaterally to the arcus
tendineus fasciae pelvis, re-creating a level II attachment.
In the apical and posterior compartment, it is located
apical and posterior to the level of the ischial spine, 
re-creating a level I support [6]. Prostheses can also be
potentially used to treat stress urinary incontinence con-
comitantly using different shaped materials [7]. The ideal
pelvic reconstructive surgery of severe cystocele should
include repair of bladder herniation, correction of
coincident stress urinary incontinence without causing
obstruction, and retention or improvement of vaginal
depth and axis [8].
Historically, the use of synthetic nonabsorbable pros-
theses, recently reviewed by Birch [9], dates to the
beginning of the 20th century with the use of metallic
silver mesh as early as 1903, which was followed by the
use of nylon mesh in 1938, and Dacron (Mersilene) in
1956. Mersilene was a popular prosthetic material for
many decades, but its use is rapidly declining in favor
of polypropylene, which is now the most commonly used
synthetic product and was introduced as Marlex in
1958 [9].
With the accumulating experience in general sur-
gery, more recent reports in the surgical literature has
suggested the routine use of synthetic prosthesis for all
primary hernia repairs. Luijendijk et al [10] reported
on the recurrence rates of inguinal hernias following
primary suture repair compared with augmented repair
employing a synthetic graft, with a 43% recurrence in
the suture repair group versus 24% in the mesh aug-
mented repairs after 3 years of follow-up. Surgical prin-
ciples for the correction of POP are similar to those
employed for abdominal wall hernias. Gynecologists
performing reconstructive pelvic floor surgery have begun
to adopt these surgical principles and are using a variety
of synthetic and biological products for both primary
and secondary prolapse surgeries. Nevertheless, great
care should be devoted to actual and theoretical short-
and long-term risks, many of which have not been fully
elucidated. In this review article, the characteristics of
the different prostheses, the use synthetic prostheses
for pelvic reconstructive surgery, and the associated
complications of prostheses are included.
Characteristics of Different Prostheses
The ideal prosthesis should be sterile, durable, noncar-
cinogenic, inexpensive, easily applied, and causes no
antigenic response but withstands remodeling by body
tissues [11]. Current prostheses are either synthetic
(absorbable, nonabsorbable or mixed) or biological
(autologous, allograft or xenograft donor tissue) for
the purpose of integrating with the host tissue and
supporting the attenuated areas.
Synthetic absorbable and nonabsorbable materials
These implants differ not only with respect to the
material (polyethylene, polypropylene, polypropylene
terephthalate, Gore-Tex) but also in terms of structure
(woven, knitted), fiber type (monofilament, multifila-
ment, monofilament/multifilament), pore size, mechan-
ical properties, shape, and surface characteristics [12].
Most commercially available synthetic prostheses in
surgical fields are listed in the Table according to the
Amid classification [13].
● Nonabsorbable materials: e.g. Prolene (Ethicon,
Somerville, NJ, USA), Marlex (Bard, Cranston, RI,
USA), Atrium (Atrium, Hudson, NH, USA), Gore-
Tex (Gore, Flagstaff, AZ, USA), Mersilene (Ethicon,
Somerville, NJ, USA), and Teflon (DuPont,
Wilmington, DE, USA), Cellgard (Hoechst-Celanese,
Charlotte, NC, USA).
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Vaginal total hysterectomy + anterior-posterior colporrhaphy
Tension-free vaginal mesh with procedural kits*
Vaginal repair of anterior, posterior compartment + mesh
Abdominal sacrocolpopexy ± mesh
Sacrospinous ligament suspension
Figure. The evolution of pelvic reconstructive surgeries.
*Include Prolift (Gynecare, Ethicon, Somerville, NJ, USA);
Perigee and Apogee (American Medical Systems, Minnetonka,
MN, USA); posterior intravaginal slingplasty (United States
Surgical, Tyco Healthcare, Norwalk, CT, USA); Nazca
(Promedon, Cordoba, Argentina).
● Absorbable materials: e.g. Vypro, Vicryl (Ethicon,
Somerville, NJ, USA).
Biological materials
Biological materials are categorized as follows:
● Xenograft: porcine small intestine submucosa (SIS;
Cook, Letchworth, UK), bovine pericardium, and
Pelvicol (Bard, Billerica, MA).
● Allograft: dura mater, fascia lata.
● Autologous material: rectus sheath, fascia lata, and
vaginal mucosa.
The newly developed absorbable material called SIS
(Cook, Lafayette, IN, USA) is also worth our attention
[14]. SIS is a natural biomaterial harvested from the
porcine small intestine and made into a biocompatible
medical product. The emergence of absorbable material
may bring a new era; however, owing to limited number
of reports in the literature, the long-term effect remains
unknown.
Since no ideal prosthesis with the various character-
istics is available, the search for the optimal prosthesis
remains uncertain.
Synthetic Prostheses for Pelvic
Reconstructive Surgery
Abdominal sacrocolpopexy
The efficacy of nonabsorbable synthetic prostheses 
for abdominal sacrocolpopexy is assured by supportive 
evidence [15]. There have been many reports in the lit-
erature on the support of the middle compartment.
First described by Lane in 1962 [16], sacrocolpopexy has
undergone numerous modifications, including the type
of prosthesis used and placement onto the anterior
and posterior walls of the vagina. In a recent comprehen-
sive review of 98 articles on abdominal sacrocolpopexy,
the success rate, when defined as lack of apical pro-
lapse postoperatively, was 78–100% and when defined
as no postoperative prolapse, was 58–100%; the follow-
up duration for most studies ranged from 6 months to
3 years. The median rate for a second operation for
POP and/or stress urinary incontinence after abdomi-
nal sacrocolpopexy was 4.4% (range, 0–18.2%) [17].
Synthetic rather than biological prostheses for bridg-
ing the vagina to the sacrum was supported by a recent
randomized trial by Culligan et al [18], who asserted
that polypropylene mesh (91% cure) was better than
cadaveric fascia lata (68% cure) for abdominal sacro-
colpopexy (p = 0.007) at 1 year of follow-up. There were
significant differences in favor of the polypropylene mesh
group at points Aa and C of the POP quantification
system, as well as overall prolapse stages [18]. Fitzgerald
et al [19] also noted poor anatomic outcomes (the
failure rate of 83% by 17 months) when freeze-dried,
irradiated donor fascia lata was used for abdominal
sacrocolpopexy.
Vaginal repair of the anterior and posterior
compartments
The data available on synthetic nonabsorbable pros-
theses are sparse and largely consist of small retrospec-
tive series with short-term follow-up. Julian [20] first
described anterior vaginal colporrhaphy with prosthetic
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Table. Classification of synthetic prostheses
Type Fiber type Pore size Component Brand names
Type I Monofilament > 75 µm Polypropylene Prolene (Ethicon, Somerville, NJ, USA)
macroporous Marlex (Bard, Billerica, MA, USA)
Atrium (Atrium, Hudson, NH, USA)
Type II Monofilament <10 µm ePTFE Gore-Tex (Gore, Flagstaff, AZ, USA)
microporous
Type III Multifilament Polyethylene Dacron (Mersilene; Ethicone, Somerville, NJ, USA)
microporous/ Teflon (DuPont, Wilmington, DE, USA) 
macroporous SurgiPro (Autosuture, Tyco Healthcare, 
Norwalk, CT, USA)
Type IV Submicronic < 1 µm Polypropylene sheet Silastic (Dow Corning, Midland, MI, USA) 
Cellgard (Hoechst-Celanese, Charlotte, 
NC, USA)
Absorbable Monofilament/ Polypropylene/ Vypro (Ethicon, Somerville, NJ, USA)
multifilament polyglactin 910
Multifilament Polyglactin 910 Vicyl (Ethicon, Somerville, NJ, USA)
ePTFE = expanded polytetrafluoroethylene.
reinforcement in 1996. The prospective study used
Marlex (Bard, Billerica, MA, USA), a type I monofila-
ment polypropylene prosthesis, which was randomly
allocated to 24 patients with anterior colporrhaphy with
or without prosthetic reinforcement, and showed suc-
cess rates of 100% and 66%, respectively, at 24 months’
follow-up; however, there was a high erosion rate of 25%
(4 /12) [20]. A retrospective analysis by Flood et al [21]
of 142 women using Marlex revealed a success rate
(prolapse less than grade 1) of 100% at a mean follow-
up of 36 months, with no prosthetic-related complica-
tions. Dwyer and O’Reilly [22] used a polypropylene
prosthesis (Atrium) in the anterior and posterior com-
partments and showed a recurrence rate of 6%. de
Tayrac et al [23] reported a recurrence rate of 8% and
seven erosions (8.3%) using the polypropylene pros-
thesis Gynemesh (Gynecare, Ethicon, Somerville, NJ,
USA) on 87 women with a mean follow-up of 24 months.
The studies using polypropylene meshes to augment
the surgically corrected anterior vaginal prolapse showed
success rates of 87% [24], 91.6% [23], and 100% [25].
The researchers concluded that the use of nonabsorbable
prosthetic reinforcement appeared to be an effective
method of preventing prolapse recurrences; however,
the concerns included the short-term follow-up periods
and material erosion rates.
Owing to the limited number of reports on graft
augmentation in the posterior vaginal wall, the data
on the effects of graft augmentation on the bowel,
bladder and sexual function are limited. Milani et al
[25] reported a prospective observational cohort of
63 women who had conventional anterior (n = 32) or
posterior (n = 31) colporrhaphies augmented with poly-
propylene mesh. Both groups had excellent anatomic
outcomes at 12 months after surgery (94% with stage 0)
but had significant increases in the rates of dyspareu-
nia. Of those who had anterior mesh repairs, 20% had
worsening dyspareunia after their repairs, while 63% of
those who had posterior mesh repairs developed wors-
ening dyspareunia [25]. The authors concluded that
while the studies showed good anatomic results with
the use of Prolene mesh for vaginal prolapse repairs,
the morbidity rates, however, were high [25]. In addi-
tion, Deffieux et al [26] reported a comparable inci-
dence of de novo dyspareunia in patients with vaginal
erosion and those without it (9% vs. 11%; p = 0.85).
The use of synthetic absorbable prostheses is a
response to the morbidity arising from the erosion rates
with the use of synthetic nonabsorbable prostheses.
Two prospective randomized controlled trials compared
synthetic absorbable prostheses, polyglactin 910 (Vicryl;
Ethicon, Somerville, NJ), with traditional transvaginal
repairs. Sand et al [27] studied 161 women (21 recurrent
and 140 primary), with significantly lower recurrence
rates found in the prosthetic-reinforced repair group
compared with the non-reinforced group (25% vs. 43%;
p = 0.002) at 12 months of follow-up. Weber et al [28]
undertook a prospective three-armed randomized con-
trolled trial on 114 patients and found that absorbable
augmented meshes (polyglactin 910 mesh) did not im-
prove anatomic results at a mean follow-up of 23 months
(range, 4.5–44 months).
Tension-free vaginal mesh (TVM) techniques with
procedural kits
The TVM techniques with procedural kits, which include
disposable insertion needles, retrieval devices and pieces
of polypropylene mesh, are increasingly being adopted,
e.g. anterior, posterior and total Prolift (Gynecare,
Ethicon, Somerville, NJ, USA), Apogee and Perigee
(American Medical Systems, Minnetonka, MN, USA),
and Nazca (Promedon, Cordoba, Argentina). These
TVM techniques with procedure kits were designed 
to offer a simple and efficient surgical technique, re-
duce the surgery time, shorten the learning curve, transfer
the anchoring arms simply and precisely, and simplify 
the tension-free system. Also, the use of monofilament
macroporous polypropylene mesh improves tissue inte-
gration, promotes tissue ingrowth, and minimizes ero-
sion and exposition risk. Therefore, they potentially offer
a minimally invasive approach by the ergonomically
designed handle system. Based on a retrospective mul-
ticentric study, the perioperative and immediate post-
operative results demonstrated a failure rate (recurrent
prolapse even asymptomatic or low grade symptomatic
prolapse) of 4.7% (5/110) [29]. The authors concluded
that the Prolift repair seems to be a safe technique to
correct POP. However, anatomic and functional results
of a long-term follow-up study has not confirmed the
effectiveness or safety of the procedure [29].
In summary, the synthetic prostheses for sacrocol-
popexy are well established yet remain controversial for
repairing isolated anterior and posterior compartment
defects. No long-term studies with sufficient patient
numbers have been conducted to conclude whether
synthetic or biological prostheses are superior for use
in vaginal surgery.
Complications of Use of Prostheses in
Pelvic Reconstructive Surgery
Mesh erosion remains a major concern in the use of
prostheses in pelvic reconstructive surgery. In the study
by Nygaard et al [17], the complications attributable
to erosion occurred in 3% of patients in 20 studies of
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abdominal sacrocolpopexy. The posterior placement
of prosthesis to the perineal body using a combined
abdominal and vaginal approach was associated with
a high sepsis and erosion rate (40%) [30].
Based on a retrospective study of 138 transvaginal
repairs of cystocele using Gynemesh or Gynemesh Soft
mesh, age was an independent predictive factor of vagi-
nal erosion (age, > 70 years; odds ratio, 3.6; p = 0.010).
On the contrary, cystocele stage of more than 2 (Baden
and Walker classification) was a protective factor against
vaginal erosion (odds ratio, 0.3; p = 0.016) [26].
Mesh erosion differs in different types of prostheses
Erosion rates vary according to the different types of
prostheses. Early experience with type II and type III
synthetic prostheses for pelvic reconstructive surgery
was associated with a significantly high postoperative
mesh erosion rate of 20–30% after Dacron or Gore-Tex
use [15,31]. The woven, multifilament nature of these
mesh materials might cause limited host tissue ingrowths,
leading to erosions, draining sinuses and fistulae. More
recently, some concern has arisen about a relatively high
erosion rate (17%) seen with the intravaginal slingplasty
(United States Surgical, Tyco Healthcare, Norwalk, CT,
USA) sling material [32]. The erosion rate decreased
to 0.5–5% by using type I synthetic prosthesis [29]. The
erosion rate of the currently available synthetic pros-
thesis has been reported to be 0.5% for polypropylene,
3.1% for polyethylene terephthalate (Mersilene; Ethicon,
Somerville, NJ, USA), 3.4% for Gore-Tex (Gore, Flagstaff,
AZ, USA), 5.0% for polyethylene (Marlex; Bard, Billerica,
MA, USA), and 5.6% for Teflon (DuPont, Wilmington,
DE, USA) [17].
Mesh erosion differs in different approaches
Erosion rates also vary according to the different types
of approaches. Visco et al [30] retrospectively analyzed
Mersilene mesh erosion rates in 273 women who had
undergone sacrocolpopexy or sacral colpoperineopexy;
the overall risk of erosion was 3.2% for abdominal
sacrocolpopexy (median time to erosion, 15.6 months)
and 4.5% for abdominal sacral colpoperineopexy
(median time to erosion, 12.4 months), by introducing
the prostheses and sutures abdominally. Erosion rate
increased to 16% when sutures were placed vaginally
and attached to an abdominally introduced mesh dur-
ing sacral colpoperineopexy (median time to erosion,
9.0 months). When the mesh was introduced vaginally,
the erosion rate peaked at 40% (median time to ero-
sion, 4.1 months). The three most recent studies of
polypropylene mesh augmenting the surgical correction
of anterior vaginal prolapse reported an erosion rate
of 8.3–13% [23–25]. Deffieux et al [26] recommended
that vaginal mesh placement should be avoided for
women with moderate cystocele, and those with total
hysterectomy and vertical incision, if possible. Managing
vaginal erosion is simple and associated with a low rate
of morbidity. However, patients should be informed of
the risk of postoperative mesh erosion.
TVM techniques with procedural kits
Analyzing the first 100 TVM procedures with proce-
dural kits revealed a 17.5% erosion rate, which fell to
2.7% when T-shaped colpotomies, concomitant hyster-
ectomy and perineal incisions were avoided [33]. In a
retrospective multicentric study of 110 patients, peri-
operative and immediate postoperative results showed
mesh exposure in five cases (4.7%), two of which required
surgical management [29]. Granuloma without exposure
was found in three cases (2.8%) [29].
The choice for better prosthetic materials
The choices for better materials are of prime importance.
Synthetic prostheses types II and III have resulted in
unacceptably high rates of postoperative erosion and
should be abandoned. One of the potential advan-
tages of absorbable or biological prostheses is the low
erosion rate. If erosion occurs, conservative manage-
ment should be used and surgery is seldom required
[9]. Although the reports in the literature are difficult
to interpret because of the diversity of studies and other
factors, synthetic grafts generally may have slightly
higher success rates but higher erosion rates, whereas
biological materials appear to be better tolerated with
lower erosion rates [9]. Current evidence suggests that
the use of monofilament, macroporous polypropylene
has the lowest incidence of infection and erosion when
compared among the nonabsorbable meshes [4].
Unanswered Questions and Discussion
The evolution of newly developed prostheses offers a
new era in pelvic reconstructive surgery. However, some
unanswered questions remain: (1) Should prostheses
be considered for primary repairs, secondary repairs
or solely in patients with risk factors for recurrence
(diabetics, obesity, steroid use, chronic respiratory dis-
ease)? (2) No ideal prostheses with the various charac-
teristics are available now. Which prosthesis is optimal:
synthetic nonabsorbable, synthetic absorbable, mixed
synthetic or biological prostheses? (3) Do the benefits
of prostheses for pelvic reconstructive surgery out-
weigh their risk of complications? Therefore, further
well-designed randomized control trials as well as basic
studies are needed to answer these questions.
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